Nearly two-thirds of patients with colorectal cancer indicate financial burdens
the ONA take:
According to a new study published in the journal Medical Care, researchers at the University of Michigan Comprehensive Cancer Center in Ann Arbor, Michigan, have found that about 62% of patients with colorectal cancer report some form of financial burden as a result of their cancer treatment.
For the study, the researchers surveyed 956 patients who had been treated for stage 3 colorectal cancer. Based on seven questions about financial burden, 29% indicated one to two areas of burden, 23% indicated three to four areas of burden, and 9% indicated 5 or more burdens. The questions referred to whether the patients had used savings, borrowed money, missed bill payments, or cut back spending on items like food, clothing, or activities.
The researchers found that the financial burden was highest among patients who received chemotherapy. In addition, younger, working patients with low-incomes were more likely to experience financial burdens as they could not afford to take time off from their jobs.
Their findings suggest that policy changes should be urged to allow support for patients who need time off from work to receive cancer care. The researchers recommend that patients speak with their physicians about their financial concerns.
About 62% of patients with colorectal cancer report some form of financial burden.
Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. The burden was greatest among patients who received chemotherapy and among younger patients who worked in low-paying jobs.
The study surveyed 956 patients who had been treated for stage 3 colorectal cancer. Among this group, chemotherapy is known to increase survival by up to 20 percent and is routinely recommended following surgery.
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Immune Thrombocytopenia (Fact Sheet)
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|